LLY Dec 2026 1040.000 call
| Previous Close | 161.00 |
| Open | 161.00 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 1,040.00 |
| Expire Date | 2026-12-18 |
| Day's Range | 161.00 - 161.00 |
| Contract Range | N/A |
| Volume | |
| Open Interest | N/A |
- Yahoo Finance Video
Hims & Hers stock falls after Eli Lilly's weight-loss drug dropped from shortage list
Eli Lilly (LLY)'s weight loss drugs Mounjaro and Zepbound are no longer facing supply constraints, as the FDA has removed them from its shortage list — signaling the pharmaceutical giant's ability to now meet market demand. In contrast, shares of competitor Hims & Hers Health (HIMS) are plummeting following this news. Market Domination hosts Madison Mills and Josh Schafer discuss the news and Citi's take on it. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Angel Smith
ZacksTop Research Reports for Exxon Mobil, Mastercard and Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), Mastercard Incorporated (MA) and The Procter & Gamble Company (PG), as well a micro-cap stock Vaso Corporation (VASO).
ZacksEli Lilly to Invest $4.5B for New Manufacturing & Research Plant
Lilly is investing $4.5 billion to build a new site for improving manufacturing and drug development.
